Richard Ammer

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ David Baker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Ammer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 7,500 $5,143 $0.6857 09 Jun 2022 Direct

Insider Reports Filed by Richard Ammer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRI Vallon Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 13:32
GRI Vallon Pharmaceuticals, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 16:08